Search research articles
Contact Us
Filters
Showing results (211-220 of 329) with videos related to
Page
of 33
Sort By:
International Journal of Antimicrobial Agents
|
September 22, 2018
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing
Thuy Nguyen, Sepideh Akhavan, Fabienne Caby, et al.
Journal of Medical Virology
|
July 20, 2004
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients
Anne-Geneviève Marcelin, Dissou Affolabi, Claire Lamotte, et al.
The Journal of Antimicrobial Chemotherapy
|
October 2, 2014
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes
Djeneba B Fofana, Charlotte Charpentier, Almoustapha I Maïga, et al.
The Journal of Infectious Diseases
|
September 16, 2011
Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy
Sidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019
Martin Martinot, Aude Jary, Samira Fafi-Kremer, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments
Basma Abdi, Mouna Chebbi, Marc Wirden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 25, 2016
Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression
Fabienne Caby, Amélie Guihot, Sidonie Lambert-Niclot, et al.
The Journal of Antimicrobial Chemotherapy
|
July 23, 2013
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies
Eve Todesco, Sophie Sayon, Slim Fourati, et al.
AIDS (London, England)
|
December 20, 2015
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial
Christine Katlama, Sidonie Lambert-Niclot, Lambert Assoumou, et al.
Antiviral Therapy
|
December 19, 2002
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial
Vincent Calvez, Dominique Costagliola, Diane Descamps, et al.
Page
of 33
Search research articles
Search
Showing results (211-220 of 329) with videos related to
Sort By:
Page
of 33
International Journal of Antimicrobial Agents
|
September 22, 2018
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing
Thuy Nguyen, Sepideh Akhavan, Fabienne Caby, et al.
Journal of Medical Virology
|
July 20, 2004
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients
Anne-Geneviève Marcelin, Dissou Affolabi, Claire Lamotte, et al.
The Journal of Antimicrobial Chemotherapy
|
October 2, 2014
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes
Djeneba B Fofana, Charlotte Charpentier, Almoustapha I Maïga, et al.
The Journal of Infectious Diseases
|
September 16, 2011
Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy
Sidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019
Martin Martinot, Aude Jary, Samira Fafi-Kremer, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments
Basma Abdi, Mouna Chebbi, Marc Wirden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 25, 2016
Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression
Fabienne Caby, Amélie Guihot, Sidonie Lambert-Niclot, et al.
The Journal of Antimicrobial Chemotherapy
|
July 23, 2013
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies
Eve Todesco, Sophie Sayon, Slim Fourati, et al.
AIDS (London, England)
|
December 20, 2015
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial
Christine Katlama, Sidonie Lambert-Niclot, Lambert Assoumou, et al.
Antiviral Therapy
|
December 19, 2002
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial
Vincent Calvez, Dominique Costagliola, Diane Descamps, et al.
Page
of 33